Back
Ares Dynamic Credit Allocation Fund Vs. Nektar Therapeutics Industry Stock Comparison
Buy
85
ARDC
Ares Dynamic Credit Allocation Fund
Last Price:
$14.57
Seasonality Move:
-0.5%
Sell
49
NKTR
Nektar Therapeutics
Last Price:
$25.43
Seasonality Move:
2.04%
Buy
85
Ares Dynamic Credit Allocation Fund (ARDC)
is a Buy
Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?
-
The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $14.54. The Score for ARDC is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
ARDC is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $24.14. The Score for NKTR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARDC Stock Price Chart
What is Ares Dynamic Credit Allocation Fund's stock price today?
-
The Ares Dynamic Credit Allocation Fund share price today is $14.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARDC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $24.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
ARDC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 71.1 | Buy |
Chaikin Money Flow: | 100600 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.17 - 14.37) | Buy |
Bollinger Bands (100): | (13.53 - 14.55) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.61 | Buy |
Relative Strength Index (14 RSI): | 62.41 | Buy |
Chaikin Money Flow: | 356028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.6 - 27.18) | Buy |
Bollinger Bands (100): | (7.48 - 18.56) | Buy |
ARDC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.36 | Buy |
20-day SMA: | 14.28 | Buy |
50-day SMA: | 14.16 | Buy |
200-day SMA: | 14.62 | Sell |
8-day EMA: | 14.38 | Buy |
20-day EMA: | 14.3 | Buy |
50-day EMA: | 14.18 | Buy |
200-day EMA: | 14.36 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24 | Buy |
20-day SMA: | 21.86 | Buy |
50-day SMA: | 14.8 | Buy |
200-day SMA: | 14.65 | Buy |
8-day EMA: | 20.01 | Buy |
20-day EMA: | 12.16 | Buy |
50-day EMA: | 5.89 | Buy |
200-day EMA: | 1.63 | Buy |
Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
Ares Dynamic Credit Allocation Fund Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |